YAP1 and small cell lung carcinoma: This is significant for a couple of reasons: i) as a transcription activator, YAP1 overexpression promotes EMT in multiple cancers (Akrida et al., 2022), and ii) YAP1 enhances chemoresistance in a subpopulation of SCLC (Pearsall et al., 2020; Wu et al., 2021).